Back
Altimmune, Inc. Stock Predictions
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
50
ALT
Altimmune, Inc.
Last Price:
$5.32
Seasonality Move:
14.35%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiAltimmune, Inc. Stock Forecast
-
Over the next 52 weeks, Altimmune, Inc. has on average historically risen by 28% based on the past 20 years of stock performance.
-
Altimmune, Inc. has risen higher in 9 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 45%
-
Is Altimmune, Inc. Stock Undervalued?The current Altimmune, Inc. [ALT] share price is $5.11. The Score for ALT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
ALT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Altimmune, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Altimmune, Inc. has on average historically risen by 28% based on the past 20 years of stock performance.
Altimmune, Inc. Stock Rating
Sell
50
Altimmune, Inc. (ALT)
is a Sell
Is Altimmune, Inc. overpriced?
-
Altimmune, Inc. has risen higher in 9 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 45%
Altimmune, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
altimmune.com
52-Week Data
52-Week High:
10.88
52-Week Low:
2.90
Prediction Charts
Market Cap:
533.2M
Price in USD:
5.11
Volume:
2.6M
Beta:
1.16
Technical Analysis
SMA50:
4.19
SMA100:
3.97
SMA200:
4.72
52-Wk Change:
-41.87%
Stock Predictions
-
Is Altimmune, Inc. stock public?Yes, Altimmune, Inc. is a publicly traded company.
-
What is the Altimmune, Inc. stock quote today?The Altimmune, Inc. stock price is 5.11 USD today.
-
How to buy Altimmune, Inc. stock online?You can buy Altimmune, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-13 | 4.18 | 4.06 | 4.22 | 4.03 |
| Nov-14 | 3.95 | 4.17 | 4.23 | 3.95 |
| Nov-17 | 4.14 | 4.20 | 4.22 | 4.07 |
| Nov-18 | 4.16 | 4.65 | 4.73 | 4.09 |
| Nov-19 | 4.54 | 4.59 | 4.75 | 4.51 |
| Nov-20 | 4.67 | 4.47 | 4.71 | 4.40 |
| Nov-21 | 4.46 | 4.81 | 4.88 | 4.44 |
| Nov-24 | 4.83 | 5.08 | 5.19 | 4.80 |
| Nov-25 | 5.10 | 5.14 | 5.25 | 4.98 |
| Nov-26 | 5.11 | 5.18 | 5.31 | 5.10 |
| Nov-28 | 5.21 | 5.26 | 5.33 | 5.15 |
| Dec-1 | 5.08 | 4.93 | 5.12 | 4.73 |
| Dec-2 | 5.00 | 4.76 | 5.00 | 4.75 |
| Dec-3 | 4.82 | 5.11 | 5.15 | 4.70 |
Altimmune, Inc. Earnings
Altimmune, Inc. Earnings Report: Per Share Altimmune, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Altimmune, Inc. Forecast Revenue Growth
Altimmune, Inc. Stock Analysis: Historical quarterly revenues per share for Altimmune, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.
* Altimmune, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.